LabGenomics Co., Ltd. (084650.KQ)
KRW 2545.0
(-3.05%)
KRW 2545.0
(-3.05%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -3.82 Billion | 68.95 Billion | 65.36 Billion | 46.37 Billion | 3.18 Billion |
| Net Income | -5.24 Billion | 47.92 Billion | 83.85 Billion | 42.76 Billion | 962.42 Million |
| Depreciation & Amortization | 5.89 Billion | 3.96 Billion | 3.33 Billion | 3.42 Billion | 3.8 Billion |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | 16.15 Million | 47.93 Million | 31.78 Million | - | - |
| Change in working capital | -5.03 Billion | 29.73 Billion | -31.2 Billion | -17.26 Billion | -3.55 Billion |
| Other non-cash items | 1.82 Billion | -244.66 Million | 45.52 Million | 102.58 Million | 1.97 Billion |
| Investing Cash Flow | -116.6 Billion | -53.31 Billion | -26.06 Billion | -8.58 Billion | -85.81 Million |
| Investments in PPE | -5.19 Billion | -38.32 Billion | -13.81 Billion | -1.51 Billion | -560.94 Million |
| Acquisitions | -81.84 Billion | -2.2 Billion | - | - | -342.7 Million |
| Investment purchases | -190.49 Billion | -195.26 Billion | -49.45 Billion | -23.32 Billion | - |
| Sales/Maturities of investments | 153.61 Billion | 182.52 Billion | 33.7 Billion | 16.79 Billion | - |
| Other Investing Activities | -204.61 Million | -47.94 Million | 3.47 Billion | -574.78 Million | 475.12 Million |
| Financing Cash Flow | 57.64 Billion | 11.44 Billion | -7.19 Billion | -959.84 Million | -1.48 Billion |
| Debt repayment | -36.8 Billion | -16 Billion | -600 Million | -108.41 Million | -1.09 Billion |
| Dividends payments | - | -3.31 Billion | - | - | - |
| Common Stock Repurchased | - | - | -6.54 Billion | - | -481.73 Million |
| Common Stock Issuance | 22.71 Billion | - | - | 331.62 Million | - |
| Other Financing Activities | -72.7 Million | -10.00 | -2.5 Billion | 100 Million | 161.32 Million |
| Accounts receivables | 11.86 Billion | 36.6 Billion | -36.87 Billion | -13.74 Billion | -2.6 Billion |
| Accounts payables | - | - | - | - | - |
| Inventory | 243.11 Million | 2.5 Billion | 2.08 Billion | -5.65 Billion | -196.37 Million |
| Other working capital | -6.44 Billion | -955.02 Million | 284.82 Million | -1.73 Billion | -754.08 Million |
| Cash at beginning of period | 98.51 Billion | 70.52 Billion | 37.83 Billion | 1.99 Billion | 399.07 Million |
| Cash at end of period | 42.32 Billion | 98.51 Billion | 70.52 Billion | 37.83 Billion | 1.99 Billion |
| Capital Expenditure | -5.19 Billion | -38.32 Billion | -13.81 Billion | -1.51 Billion | -560.94 Million |
| Effect of forex changes on cash | 349.43 Million | -14.3 Million | -131.82 Million | -988.5 Million | -14.87 Million |
| Net cash flow / Change in cash | -56.18 Billion | 27.98 Billion | 32.69 Billion | 35.83 Billion | 1.59 Billion |
| Free Cash Flow | -9.02 Billion | 30.62 Billion | 51.54 Billion | 44.85 Billion | 2.62 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 226.22 Million | -9.09 Billion | -5.24 Billion | -11.1 Billion | -1.71 Billion | 3.25 Billion |
| Depreciation & Amortization | 2.31 Billion | 2.2 Billion | 5.89 Billion | 2.83 Billion | 1.06 Billion | 961.06 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 111.77 Million | 122.46 Million | 16.15 Million | - | - | 4.33 Million |
| Change in working capital | -4.19 Billion | 99.77 Million | -5.03 Billion | 5.66 Billion | -5.42 Billion | -2.49 Billion |
| Other non-cash items | 301.91 Million | 725.35 Million | 1.82 Billion | 1.76 Billion | -356.73 Million | 874.1 Million |
| Investing Cash Flow | 11.64 Billion | -15.97 Billion | -116.6 Billion | -70.08 Billion | 56.42 Billion | 122.87 Million |
| Investments in PPE | -1.11 Billion | -1.4 Billion | -5.19 Billion | -895.49 Million | -206.76 Million | -238.06 Million |
| Acquisitions | - | - | -81.84 Billion | -78.41 Billion | - | -1.02 Billion |
| Investment purchases | - | -15 Billion | -190.49 Billion | 183.31 Billion | -39.85 Billion | -119.37 Billion |
| Sales/Maturities of investments | - | 216.11 Million | 153.61 Billion | -174.41 Billion | 96.43 Billion | 120.64 Billion |
| Other Investing Activities | 12.76 Billion | 630.43 Million | -204.61 Million | 226.59 Million | 41.84 Million | 36.86 Million |
| Financing Cash Flow | -494.54 Million | -543.87 Million | 57.64 Billion | -4.07 Billion | -25.4 Million | -648.31 Million |
| Debt repayment | -645.82 Million | -439.7 Million | -36.8 Billion | -3.2 Billion | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 22.71 Billion | - | - | - |
| Other Financing Activities | 151.27 Million | -104.17 Million | -72.7 Million | -72.7 Million | 330 Million | -648.31 Million |
| Accounts receivables | -1.79 Billion | 2.92 Billion | 11.86 Billion | 12.82 Billion | -2.64 Billion | 2.07 Billion |
| Accounts payables | - | - | - | - | - | - |
| Inventory | -481.41 Million | -17.64 Million | 243.11 Million | 27.4 Million | -285.81 Million | 261.89 Million |
| Other working capital | -1.92 Billion | -665.54 Million | -6.44 Billion | -3.7 Billion | 622.32 Million | -1.85 Billion |
| Cash at beginning of period | 19.43 Billion | 42.32 Billion | 98.51 Billion | 34.23 Billion | 57.37 Billion | 59.07 Billion |
| Cash at end of period | 29.53 Billion | 19.43 Billion | 42.32 Billion | 42.32 Billion | 34.23 Billion | 57.37 Billion |
| Capital Expenditure | -1.11 Billion | -1.4 Billion | -5.19 Billion | -895.49 Million | -206.76 Million | -238.06 Million |
| Effect of forex changes on cash | 188.7 Million | 282.71 Million | 349.43 Million | 86.46 Million | -1.67 Billion | 108.18 Million |
| Net cash flow / Change in cash | 10.1 Billion | -22.88 Billion | -56.18 Billion | 8.08 Billion | -23.14 Billion | -1.7 Billion |
| Free Cash Flow | -2.35 Billion | -8.05 Billion | -9.02 Billion | 4.06 Billion | -7.11 Billion | -1.52 Billion |
NC5A
300611
603179
HGLD
SKCIL
BEAUTY